10-K.Info (Beta Test)
Courtesy of Short Sands, LLC
10-K.Info (Beta Test)
Courtesy of Short Sands, LLC

JOHNSON & JOHNSON

Ticker: JNJ   Fiscal Year: 2012

Consolidated Statements of Earnings

Period Ending Dec 30, 2012 10-K (Filed: Feb 22, 2013)

(In Millions, except shares in Thousands)
 12 Months Ended12 Months Ended12 Months Ended
 Dec 30, 2012Jan 1, 2012Jan 2, 2011
Sales to customers
$
67,224
65,03061,587
Cost of products sold21,65820,36018,792
Gross profit45,56644,67042,795
 
Selling, marketing and administrative expenses20,86920,96919,424
Research and development expense7,6657,5486,844
In-process research and development1,16300
Interest income(64)(91)(107)
Interest expense, net of portion capitalized532571455
Other (income) expense, net1,6262,743(768)
Restructuring expense05690
Earnings before provision for taxes on income13,77512,36116,947
 
Provision for taxes on income3,2612,6893,613
Net Earnings10,5149,67213,334
 
Add: Net Loss Attributable to Noncontrolling Interest33900
Net earnings attributable to Johnson & Johnson10,8539,67213,334
 
Net earnings per share attributable to Johnson & Johnson
Basic3.943.544.85
Diluted3.863.494.78
Cash dividends per share2.402.252.11
Average shares outstanding
Basic2,753,3002,736,0002,751,400
Diluted2,812,6002,775,3002,788,800
External Links 
JOHNSON & JOHNSON (JNJ) Fiscal Year 2012
Statements of 10-K in Excel https://www.sec.gov/.../Financial.xlxs
Complete 10-K in HTML https://www.sec.gov/.../10-K.html
Complete 10-K in XBRL https://www.sec.gov/.../10-K-xbrl.zip